RACC on Nasdaq

Research Alliance Corp III

Pharmaceutical preparations company in the Cayman Islands. Summary from the record

Price unavailable

Last updated Oct 19, 2026.

Overview

Compare with another stock.

  • TickerRACC on Nasdaq1
  • IndustryPharmaceutical Preparations1
  • HeadquartersNew York, New York1
  • Incorporated inCayman Islands2
  • Business address600 Fifth Avenue, 23Rd Floor, New York, Ny 100202
  • Filer categoryNon-accelerated filer, Smaller reporting company, Emerging growth company2

Leadership

Who has led Research Alliance Corp III, and when. Pick a name to see everywhere that person has worked.

Chief financial officer

  1. Francis Sherman Adams2026–now

Chief operating officer

  1. Henry William Stusnick2026–now
Board members and other officers (2)

Timeline

  1. May 19, 2026New chief executive Matthew Hammond becomes CEO3

Filings

41 filings to the SEC since October 2021: 2 quarterly reports, 3 major events, 8 insider forms, 13 large holders, 15 other. The latest 20:

  1. Oct 7, 2026SCHEDULE 13G EDGAR
  2. Sep 28, 2026S-4/A EDGAR
  3. Sep 16, 2026425 EDGAR
  4. Sep 11, 2026425 EDGAR
  5. Sep 11, 2026SCHEDULE 13G EDGAR
  6. Aug 24, 2026S-4 EDGAR
  7. Aug 14, 2026SCHEDULE 13G EDGAR
  8. Aug 14, 2026SCHEDULE 13G EDGAR
  9. Aug 14, 2026SCHEDULE 13G EDGAR
  10. Aug 13, 2026SCHEDULE 13G EDGAR
  11. Aug 12, 202610-Q EDGAR
  12. Aug 5, 2026425 EDGAR
  13. Aug 3, 2026SCHEDULE 13G EDGAR
  14. Jul 29, 2026425 EDGAR
  15. Jul 28, 2026SCHEDULE 13D/A EDGAR
  16. Jul 28, 2026425 EDGAR
  17. Jul 27, 2026425 EDGAR
  18. Jul 27, 20268-K EDGAR
  19. Jul 2, 202610-Q EDGAR
  20. May 29, 2026SCHEDULE 13D EDGAR

The 41 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.